I had never heard of it either until after attending a SCAB conference a few months ago. Apparently you can add Combs AHG (IgG) to bind to the antibodies that are causing a positive DAT. This will then block those antibodies from reacting when phenotyping a patient through the AHG phase. How or why this doesn't block the antigen when phenotyping I do not know? But I was told it doesn't. I was also told this technique is mainly used for those patients with a strong postive DAT, where the DAT is still reacting after treatment with EGA. Thanks,